{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:30:04Z","timestamp":1773300604883,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.vph.2021.106856","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T02:43:19Z","timestamp":1616121799000},"page":"106856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["In silico Nigellidine (N. sativa) bind to viral spike\/active-sites of ACE1\/2, AT1\/2 to prevent COVID-19 induced vaso-tumult\/vascular-damage\/comorbidity"],"prefix":"10.1016","volume":"138","author":[{"given":"Smarajit","family":"Maiti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehak","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vph.2021.106856_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.vph.2021.106856_bb0010","first-page":"cvaa097","article-title":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 [published online ahead of print, 2020 Apr 15]","author":"Kreutz","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2021.106856_bb0015","article-title":"Is the ACE2 overexpression a risk factor for COVID-19 infection? [published online ahead of print, 2020 Apr 4]","author":"Gracia-Ramos","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.vph.2021.106856_bb0020","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2021.106856_bb0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"10235","key":"10.1016\/j.vph.2021.106856_bb0030","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2021.106856_bb0035","article-title":"Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease 2019 (COVID-19) [published online ahead of print, 2020 May 17]","author":"Bourgonje","year":"2020","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.vph.2021.106856_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.18087\/cardio.2020.4.n1122","article-title":"Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers","volume":"60","author":"Mareev","year":"2020","journal-title":"Kardiologiia"},{"key":"10.1016\/j.vph.2021.106856_bb0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.smim.2012.04.005","article-title":"Changesin primary lymphoid organs with aging","volume":"24","author":"Chinn","year":"2012","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.vph.2021.106856_bb0050","article-title":"Is the kidney a target of SARS-CoV-2? [published online ahead of print, 2020 May 15]","author":"Mart\u00ednez-Rojas","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.vph.2021.106856_bb0055","first-page":"2020040247","article-title":"Epigallocatechin-gallate and theaflavin-gallate interaction in SARS CoV-2 spike-protein central-channel with reference to the hydroxychloroquine interaction: bioinformatics and molecular docking study","author":"Maiti","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.vph.2021.106856_bb0060","article-title":"The renin-angiotensin system - a therapeutic target in COVID-19? [published online ahead of print, 2020 May 15]","author":"Sturrock","year":"2020","journal-title":"Clin. Med."},{"key":"10.1016\/j.vph.2021.106856_bb0065","article-title":"Urgent need for evaluating agonists of Angiotensin-(1\u20137)\/Mas receptor axis for treatment of patients with COVID-19 [published online ahead of print, 2020 May 7]","author":"Shete","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.vph.2021.106856_bb0070","series-title":"CCP4 Newsletter On Protein Crystallography","first-page":"82","article-title":"Pymol: An open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002"},{"issue":"1","key":"10.1016\/j.vph.2021.106856_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/prot.10397","article-title":"Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking","volume":"52","author":"Schneidman-Duhovny","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.vph.2021.106856_bb0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2105-13-158","article-title":"Protein-protein binding site identification by enumerating the configurations","volume":"13","author":"Guo","year":"2012","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"10.1016\/j.vph.2021.106856_bb0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng."},{"issue":"8","key":"10.1016\/j.vph.2021.106856_bb0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.vph.2021.106856_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21932","article-title":"(\u2212)-Epigallocatechin-3-gallate inhibits human angiotensin-converting enzyme activity through an autoxidation-dependent mechanism","volume":"31","author":"Liu","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"18","key":"10.1016\/j.vph.2021.106856_bb0100","doi-asserted-by":"crossref","first-page":"999710002","DOI":"10.1073\/pnas.96.18.9997","article-title":"The maximal affinity of ligands","volume":"96","author":"Kuntz","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.vph.2021.106856_bb0105","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1021\/acs.jpclett.7b02337","article-title":"Tipping the scales: spectroscopic tools for intermolecular energy balances","volume":"8","author":"Poblotzki","year":"2017","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.vph.2021.106856_bb0110","series-title":"Fundamentals of Physics","article-title":"Electric potential","author":"Halliday","year":"1997"},{"key":"10.1016\/j.vph.2021.106856_bb0115","series-title":"Electricity and Magnetism","first-page":"16","author":"Purcell","year":"2013"},{"issue":"4","key":"10.1016\/j.vph.2021.106856_bb0120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ijforecast.2006.03.001","article-title":"Another look at measures of forecast accuracy","volume":"22","author":"Hyndman","year":"2006","journal-title":"Int. J. Forecast."},{"key":"10.1016\/j.vph.2021.106856_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.vph.2021.106856_bb0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2021.106856_bb0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2021.106856_bb0140","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","author":"Liu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.vph.2021.106856_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues [published online ahead of print, 2020 Apr 27]","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vph.2021.106856_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","volume":"3","author":"Taubenberger","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.vph.2021.106856_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vph.2021.106856_bb0160","article-title":"Increasing host cellular receptor\u2014angiotensin-converting enzyme 2 (ace2) expression by coronavirus may facilitate 2019-nCoV infection","author":"Wang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.vph.2021.106856_bb0165","first-page":"219","article-title":"Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia","volume":"43","author":"Sun","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.vph.2021.106856_bb0170","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.vph.2021.106856_bb0175","first-page":"1016","article-title":"Angiotensin converting enzyme inhibitors and pulmonary hypertension","volume":"116","author":"Martiniuc","year":"2012","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi"},{"issue":"5","key":"10.1016\/j.vph.2021.106856_bb0180","doi-asserted-by":"crossref","first-page":"H2306","DOI":"10.1152\/ajpheart.00601.2006","article-title":"Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature","volume":"292","author":"Ishikawa","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"19","key":"10.1016\/j.vph.2021.106856_bb0185","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","article-title":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","volume":"41","author":"Inciardi","year":"2020","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.vph.2021.106856_bb0190","first-page":"381","article-title":"COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept [published online ahead of print, 2020 May 4]","volume":"39","author":"Gris","year":"2020","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"10.1016\/j.vph.2021.106856_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.vph.2021.106856_bb0200","article-title":"Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?","volume":"26","author":"Park","year":"2020","journal-title":"Clin. Hypertens."},{"issue":"5","key":"10.1016\/j.vph.2021.106856_bb0205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCRESAHA.109.203323","article-title":"Angiotensin II-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and FasL-Fas engagement [retracted in: Circ Res. 2016 Feb 5;118(3):e31]","volume":"105","author":"Tan","year":"2009","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.vph.2021.106856_bb0210","doi-asserted-by":"crossref","first-page":"H2116","DOI":"10.1152\/ajpheart.00551.2005","article-title":"ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression","volume":"290","author":"Li","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.vph.2021.106856_bb0215","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI7886","article-title":"Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation","volume":"104","author":"Tsutsumi","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"7\u20138","key":"10.1016\/j.vph.2021.106856_bb0220","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.repc.2014.02.011","article-title":"Cardiovascular effects of the angiotensin type 2 receptor","volume":"33","author":"Faria-Costa","year":"2014","journal-title":"Rev. Port. Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2021.106856_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13105-012-0182-y","article-title":"Renal function and arterial bloodpressure alterations after exposure to acetaminophen with apotential role of Nigella sativaoil in adult male rats","volume":"69","author":"Ahmed","year":"2013","journal-title":"J. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.vph.2021.106856_bb0230","first-page":"4","article-title":"Possible mechanism(s) for relaxant effect of aqueous andmacerated extracts from Nigella sativaon tracheal chains ofguinea pig","author":"Boskabady","year":"2004","journal-title":"BMC Pharmacol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189121000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189121000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:19:48Z","timestamp":1761527988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189121000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":46,"alternative-id":["S1537189121000288"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2021.106856","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico Nigellidine (N. sativa) bind to viral spike\/active-sites of ACE1\/2, AT1\/2 to prevent COVID-19 induced vaso-tumult\/vascular-damage\/comorbidity","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2021.106856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106856"}}